Vanguard Group
SURG

Vanguard Group’s SYNERGETICS USA, INC. SURG Stock Holding History

Vanguard Group’s Portfolio SURG Stock Details SURG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-720,168
Closed -$4.73M – 4258
2015
Q3 		$4.73M Buy
720,168
+59,203
+9% +$307K ﹤0.01% 2993
2015
Q2 		$3.11M Buy
660,965
+21,290
+3% +$103K ﹤0.01% 3222
2015
Q1 		$3.45M Buy
639,675
+29,654
+5% +$140K ﹤0.01% 3179
2014
Q4 		$2.65M Buy
610,021
+26,211
+4% +$94.2K ﹤0.01% 3179
2014
Q3 		$1.99M Buy
583,810
+48,920
+9% +$153K ﹤0.01% 3269
2014
Q2 		$1.66M Hold
534,890
– – ﹤0.01% 3334
2014
Q1 		$1.63M Buy
534,890
+9,900
+2% +$33.5K ﹤0.01% 3307
2013
Q4 		$1.9M Hold
524,990
– – ﹤0.01% 3201
2013
Q3 		$2.39M Hold
524,990
– – ﹤0.01% 3068
2013
Q2 		$2.07M Buy
+524,990
New +$1.73M ﹤0.01% 3054

Vanguard Group's SURG Position: Q4 2015 in Review

Vanguard Group sold out of SYNERGETICS USA, INC. (SURG) in Q4 2015, closing a stake of 720,168 shares — an estimated $4.73M sold.

Vanguard Group first reported a position in SURG in Q2 2013 and held it in 10 quarters. The position peaked at $4.73M in Q3 2015. 0 funds tracked by Wall St. Rank hold SURG as of Q4 2015.

  • Vanguard Group reported no remaining SYNERGETICS USA, INC. position as of Q4 2015 after selling out during the quarter.
  • Vanguard Group sold 720,168 SYNERGETICS USA, INC. shares in Q4 2015, an estimated $4.73M.
  • Vanguard Group first reported a position in SYNERGETICS USA, INC. in Q2 2013 and held it in 10 quarters.
  • Vanguard Group's SYNERGETICS USA, INC. position peaked at $4.73M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held SYNERGETICS USA, INC. as of Q4 2015.

Based on Vanguard Group's 13F filing for Q4 2015, filed 8 Feb 2016.